Skip to main content
. Author manuscript; available in PMC: 2018 Jul 31.
Published in final edited form as: Surg Obes Relat Dis. 2016 Sep 28;13(2):334–343. doi: 10.1016/j.soard.2016.09.022

Table 3.

Associationsa between sociodemographic and clinical characteristics and sexual function among women with severe obesity prior to bariatric surgery.

Lower frequency of sexual desire
Lower frequency of sexual activity
Higher degree physical health limits sexual activity
Lower satisfaction with sex life
Lower IWQOL-Lite sexual life score
OR (95%CI) P OR (95%CI) P OR (95%CI) P OR (95%CI) P β (95%CI) P
Age, per 10 year 1.56 (1.31–1.86) <.0001 1.60 (1.35–1.90) <.0001 1.11 (0.93–1.33) 0.23 1.00 (0.84–1.19) 0.98 1.06 (−0.89–3.02) 0.29
White race (Ref.=black/other race) 1.61 (1.09–2.36) 0.02 1.53 (1.04–2.25) 0.03 1.19 (0.80–1.76) 0.39 1.58 (1.07–2.33) 0.02 10.03 (5.77–14.30) <.0001
Hispanic ethnicity (Ref.=No) 0.69 (0.36–1.32) 0.26 1.22 (0.64–2.32) 0.55 1.00 (0.53–1.92) 0.99 0.79 (0.42–1.50) 0.48 3.90 (−3.77–11.57) 0.32
Education (Ref.= College degree) 0.001
    Some college 1.22 (0.92–1.63)
    High school degree or less 1.92 (1.36–2.71)
Not married/living as married (Ref.=Yes) 1.26 (0.96–1.66) 0.09 2.45 (1.86–3.23) <.0001 0.28 (0.21–0.37) <.0001 1.00 (0.76–1.31) 0.97 0.10 (−2.98–3.19) 0.95
Alcohol use disorder symptoms (Ref.=Yes) 1.98 (1.18–3.32) 0.01
BMI, per 5 kg/m2 0.94 (0.86–1.03) 0.16 1.06 (0.97–1.16) 0.19 1.14 (1.04–1.25) 0.004 0.94 (0.86–1.03) 0.19 −0.29 (−1.29–0.72) 0.58
Beck Depression Inventory score, per 5 points 1.33 (1.20–1.48) <.0001 1.25 (1.13–1.39) <.0001 1.89 (1.70–2.11) <.0001 1.84 (1.65–2.05) <.0001 9.52 (8.36–10.68) <.0001
Cardiovascular disease (Ref.=No) 2.35 (1.30–4.25) 0.005 12.64 (5.83–19.45) 0.0003
Urinary incontinence (Ref.=No) 1.68 (1.29–2.19) 0.0001 1.64 (1.26–2.13) 0.0002 7.90 (4.95–10.84) <.0001
Menopausal (Ref.=No) 1.49 (0.96–2.30) 0.07 1.69 (1.09–2.62) 0.02 1.02 (0.66–1.59) 0.92 0.99 (0.64–1.54) 0.98 −4.15 (−9.05–0.75) 0.10
Prior live or still birth (Ref=No) −3.68 (−6.89–−0.48) 0.02
Antidepressant medications that may decrease sexual function b (Ref.=No) 1.61 (1.22–2.12) 0.001 1.60 (1.21–2.12) 0.001 1.42 (1.07–1.87) 0.01 1.30 (0.98–1.72) 0.07 4.54 (1.42–7.66) 0.004
Medications that may increase sexual function c (Ref.=No) 0.87 (0.53–1.42) 0.57 1.05 (0.64–1.73) 0.85 0.72 (0.44–1.19) 0.20 1.64 (1.26–2.13) 0.19 1.31 (−4.28–6.91) 0.65
Hormonal medications with unknown impact on sexual functiond 2.02 (1.21–3.37) 0.01
a

Adjusted odds ratios (OR)a from mixed effects ordinal logistic regression models or Beta coefficients from a generalized linear mixed model and 95% CI are reported. OR represent the odds of being in the next lower category

b

Antidepressant medications other than bupropion, trazodone, mirtazapine or nefazodone.

c

Phosphodiesterase type 5 inhibitors and bupropion.

d

Estrogens, progestins, and androgens, either alone or in combination.